Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C

被引：0
|
作者：
Shivakumar Narayanan
Kerry Townsend
Thomas Macharia
Adrian Majid
Amy Nelson
Robert R. Redfield
Shyam Kottilil
Rohit Talwani
Anu Osinusi
机构：
[1] University of Maryland School of Medicine,Division of Infectious Diseases, Institute of Human Virology
[2] National Institutes of Health,Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases
来源：
Hepatology International | 2014年 / 8卷
关键词：
Sofosbuvir; Ribavirin; HCV monoinfection; Adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：560 / 566
页数：6
相关论文
共 50 条
  • [41] Patient-Reported Outcomes in Chronic Hepatitis C Patients With Cirrhosis Treated With Ribavirin-Containing Regimens: Sofosbuvir/Velpatasvir and Ribavirin or Sofosbuvir and Ribavirin
    Younossi, Zobair M.
    Stepanova, Maria
    Feld, Jordan
    Zeuzem, Stefan
    Sulkowski, Mark
    Foster, Graham R.
    Mangia, Alessandra
    Charlton, Michael R.
    O'Leary, Jacqueline G.
    Curry, Michael
    Nader, Fatema
    Hunt, Sharon
    GASTROENTEROLOGY, 2016, 150 (04) : S1046 - S1046
  • [42] Firstline treatment for hepatitis C: combination interferon/ribavirin versus interferon monotherapy
    Lai, MY
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 : E130 - E133
  • [43] Interferon Alfacon-1 and Ribavirin Versus Interferon α-2b and Ribavirin in the Treatment of Chronic Hepatitis C
    Maria H. Sjogren
    Robert Sjogren
    Kent Holtzmuller
    Bradley Winston
    Betty Butterfield
    Stanley Drake
    Amber Watts
    Robin Howard
    Milton Smith
    Digestive Diseases and Sciences, 2005, 50 : 727 - 732
  • [44] Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryoglobulinemia
    Saadoun, David
    Rigon, Mathieu Resche
    Sene, Damien
    Terrier, Benjamin
    Karras, Alexandre
    Perard, Laurent
    Schoindre, Yoland
    Coppere, Brigitte
    Blanc, Francois
    Musset, Lucile
    Piette, Jean-Charles
    Rosenzwajg, Michele
    Cacoub, Patrice
    BLOOD, 2010, 116 (03) : 326 - 334
  • [45] Sofosbuvir and Ribavirin With or Without Pegylated Interferon for Hepatitis C Genotype 3: A Real World Experience
    Abbas, Zaigham
    Saad, Muhammad
    Nadeem, Ramlah
    Jawed, Fahad
    Abbas, Minaam
    HEPATITIS MONTHLY, 2017, 17 (04)
  • [46] Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
    Hauser, Goran
    Awad, Tahany
    Brok, Jesper
    Thorlund, Kristian
    Stimac, Davor
    Mabrouk, Mahasen
    Gluud, Christian
    Gluud, Lise Lotte
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (02):
  • [47] Therapy of hepatitis C: Alpha interferon and ribavirin
    Reichard, O
    Schvarcz, R
    Weiland, O
    HEPATOLOGY, 1997, 26 (03) : S108 - S111
  • [48] Hepatitis C Cutaneous Reactions to Interferon and Ribavirin
    Voos, Dunja
    AKTUELLE DERMATOLOGIE, 2014, 40 (06) : 216 - 216
  • [49] Comparison of interferon, ribavirin and combined interferon with ribavirin in chronic hepatitis C with cirrhosis: An interim report
    Sherif, SMAF
    Sobhy, AA
    HEPATOLOGY, 1996, 23 (01) : P237 - P237
  • [50] Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
    Gallacher, Jennifer
    Taha, Yusri
    Filipe, Ana da Silva
    Ijaz, Samreen
    McPherson, Stuart
    IDCASES, 2023, 32
12345